Hudson Bay Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39K Hold
325,000
﹤0.01% 1276
2025
Q4
$101K Hold
325,000
﹤0.01% 1023
2025
Q3
$94.3K Hold
325,000
﹤0.01% 1075
2025
Q2
$94.2K Hold
325,000
﹤0.01% 1231
2025
Q1
$65K Buy
+325,000
New +$57.2K ﹤0.01% 1180

Other funds holding TDACW

Hudson Bay Capital Management's TDACW Position: Q1 2026 in Review

Hudson Bay Capital Management held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 325,000 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1276.

Hudson Bay Capital Management first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $101K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Hudson Bay Capital Management held 325,000 shares of Translational Development Acquisition Corp Warrants worth $39K as of Q1 2026.
  • Hudson Bay Capital Management left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1276 holding.
  • Hudson Bay Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • Hudson Bay Capital Management's Translational Development Acquisition Corp Warrants position peaked at $101K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.